Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Acyl coenzyme A:cholesterol acyltransferase 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Echinococcus granulosus | sterol O acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Echinococcus multilocularis | sterol O acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Schistosoma japonicum | ko:K00637 sterol O-acyltransferase [EC2.3.1.26], putative | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Schistosoma mansoni | sterol O-acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Dictyostelium discoideum | diacylglycerol O-acyltransferase 1 | Acyl coenzyme A:cholesterol acyltransferase 1 | 545 aa | 547 aa | 22.3 % |
Neospora caninum | sterol O-acyltransferase, putative | Acyl coenzyme A:cholesterol acyltransferase 1 | 545 aa | 510 aa | 21.2 % |
Toxoplasma gondii | acyl-CoA:cholesterol acyltransferase alpha ACAT1-alpha | Acyl coenzyme A:cholesterol acyltransferase 1 | 545 aa | 510 aa | 24.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | ingi protein (ORF1) | 0.0155 | 0.0484 | 0.0309 |
Plasmodium vivax | glycylpeptide N-tetradecanoyltransferase, putative | 0.0179 | 0.0799 | 0.5 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0155 | 0.0484 | 0.0309 |
Echinococcus multilocularis | sterol O acyltransferase 1 | 0.0264 | 0.1906 | 1 |
Plasmodium falciparum | glycylpeptide N-tetradecanoyltransferase | 0.0179 | 0.0799 | 0.5 |
Trypanosoma brucei | N-myristoyl transferase, putative | 0.0179 | 0.0799 | 0.0925 |
Schistosoma mansoni | hypothetical protein | 0.0535 | 0.5431 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0264 | 0.1906 | 1 |
Schistosoma mansoni | N-myristoyltransferase | 0.0179 | 0.0799 | 0.0925 |
Trypanosoma brucei | N-myristoyltransferase | 0.0179 | 0.0799 | 0.0925 |
Echinococcus granulosus | sterol O acyltransferase 1 | 0.0264 | 0.1906 | 1 |
Entamoeba histolytica | glycylpeptide N-tetradecanoyltransferase, putative | 0.0179 | 0.0799 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | ribonuclease HI | 0.0143 | 0.0326 | 0.5 |
Echinococcus granulosus | glycylpeptide N tetradecanoyltransferase | 0.0179 | 0.0799 | 0.299 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.0179 | 0.0799 | 1 |
Onchocerca volvulus | Ribonuclease H1 homolog | 0.0143 | 0.0326 | 0.5 |
Trichomonas vaginalis | N-myristoyl transferase, putative | 0.0179 | 0.0799 | 1 |
Brugia malayi | N-myristoyltransferase 2 | 0.0179 | 0.0799 | 1 |
Treponema pallidum | ribonuclease H (rnhA) | 0.0143 | 0.0326 | 0.5 |
Giardia lamblia | CDC72 | 0.0179 | 0.0799 | 1 |
Schistosoma mansoni | sterol O-acyltransferase 1 | 0.0264 | 0.1906 | 0.3094 |
Trypanosoma brucei | retrotransposon hot spot protein 4 (RHS4), interrupted | 0.0155 | 0.0484 | 0.0309 |
Leishmania major | N-myristoyl transferase, putative | 0.0179 | 0.0799 | 1 |
Mycobacterium tuberculosis | Naphthoate synthase MenB (dihydroxynaphthoic acid synthetase) (DHNA synthetase) | 0.0885 | 1 | 0.5 |
Toxoplasma gondii | ribonuclease HI protein | 0.0143 | 0.0326 | 0.5 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.0179 | 0.0799 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0238 | 0.157 | 0.6969 |
Echinococcus multilocularis | glycylpeptide N tetradecanoyltransferase | 0.0179 | 0.0799 | 0.299 |
Trypanosoma brucei | RNA helicase, putative | 0.0535 | 0.5431 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0155 | 0.0484 | 0.0309 |
Trichomonas vaginalis | ribonuclease H1, putative | 0.0143 | 0.0326 | 0.4086 |
Mycobacterium ulcerans | naphthoate synthase | 0.0885 | 1 | 0.5 |
Trypanosoma brucei | unspecified product | 0.0155 | 0.0484 | 0.0309 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Delta HDL (functional) | = 207 % | Chronic in vivo activity of the compound was measured by the concentration of high density lipoproteins (HDL) in cholesterol fed rats | ChEMBL. | 8632431 |
Delta HDL (functional) | = 207 % | Chronic in vivo activity of the compound was measured by the concentration of high density lipoproteins (HDL) in cholesterol fed rats | ChEMBL. | 8632431 |
Delta TC (functional) | = -77 % | Acute in vivo activity measured by total plasma cholesterol concentration levels (TC) at 30 mg/kg dose | ChEMBL. | 8632431 |
Delta TC (functional) | = -69 % | Chronic in vivo activity of the compound was measured by the total cholesterol concentration levels in cholesterol fed rats | ChEMBL. | 8632431 |
Delta TC (functional) | = -69 % | Chronic in vivo activity of the compound was measured by the total cholesterol concentration levels in cholesterol fed rats | ChEMBL. | 8632431 |
Delta TC (functional) | = -63 % | Acute in vivo activity of the compound was measured by the total plasma cholesterol concentration levels(TC) at dose 3 mg/kg | ChEMBL. | 8632431 |
Delta TC (functional) | = -63 % | Acute in vivo activity of the compound was measured by the total plasma cholesterol concentration levels(TC) at dose 3 mg/kg | ChEMBL. | 8632431 |
IC50 (binding) | = 0.51 uM | In vitro inhibitory activity against acyl coenzyme A:cholesterol acyltransferase 1 in microsomes of rat liver | ChEMBL. | 8632431 |
IC50 (binding) | = 0.51 uM | In vitro inhibitory activity against acyl coenzyme A:cholesterol acyltransferase 1 in microsomes of rat liver | ChEMBL. | 8632431 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.